Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dovitinib in Colorectal and Pancreas Cancers
NCT01888965Phase 2Terminated
- Sponsor
- Georgetown University
- Start
- Oct 2013
- Primary completion
- Aug 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dovitinib in colorectal cancer (CRC), pancreatic cancer (PC), sponsored by Georgetown University. Started Oct 2013; status: terminated.
02
Drugs
dovitinib
03
Conditions
colorectal cancer (CRC)pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT01888965.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01888965.